Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis

Detalhes bibliográficos
Autor(a) principal: Vieira, Bitia
Data de Publicação: 2015
Outros Autores: Costa, Andreia, Videira, Gonçalo, Sá, Maria José, Abreu, Pedro
Tipo de documento: Artigo
Idioma: eng
por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562
Resumo: Background: Autonomic nervous system dysfunction is commonly seen in multiple sclerosis patients and should be explored in the routine evaluation. Composite Autonomic Symptom Score questionnaire was validated as a self-assessment instrument of autonomic symptoms.Objectives: Determine the frequency of autonomic symptoms in multiple sclerosis patients through a Portuguese version of Composite Autonomic Symptom Score; compare questionnaire results between patients and a control group; assess the feasibility of this questionnaire application in multiple sclerosis Portuguese patients.Material and Methods: This case-control study used a Portuguese translated version of Composite Autonomic Symptom Score to determine the frequency of autonomic symptoms in multiple sclerosis patients.Results: One-hundred and three relapsing-remitting multiple sclerosis patients – median age 41 years, median disease duration 6 years, median EDSS score 1 - and 80 healthy subjects were included. Alterations in autonomic function were reported in 97.1% of the cases, with statistical significance in orthostatic intolerance and gastrointestinal domain scores. Nevertheless, the difference between multiple sclerosis patients (41.7%) without confounding factors that could interfere with autonomic dysfunction (i.e. comorbidities or medications) and controls showed no statistical significance.Discussion: Our results may be related to the short disease duration, young age and lowdisability status of our patients unaffected by confounding factors. The questionnaire was not designed specifically for multiple sclerosis and it may not be as sensible to early autonomic symptoms as to more severe manifestations.Conclusions: Further studies are needed to achieve more robust results, validate this questionnaire and assess its application in multiple sclerosis patients in Portugal.Keywords: Autonomic Nervous System; Multiple Sclerosis; Portugal; Questionnaires.
id RCAP_bfeaa6888e08718b6c3c49a3f7413114
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/5562
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Prevalence of Autonomic Dysfunction in Patients with Multiple SclerosisPrevalência da Disfunção Autonómica em Doentes com Esclerose MúltiplaBackground: Autonomic nervous system dysfunction is commonly seen in multiple sclerosis patients and should be explored in the routine evaluation. Composite Autonomic Symptom Score questionnaire was validated as a self-assessment instrument of autonomic symptoms.Objectives: Determine the frequency of autonomic symptoms in multiple sclerosis patients through a Portuguese version of Composite Autonomic Symptom Score; compare questionnaire results between patients and a control group; assess the feasibility of this questionnaire application in multiple sclerosis Portuguese patients.Material and Methods: This case-control study used a Portuguese translated version of Composite Autonomic Symptom Score to determine the frequency of autonomic symptoms in multiple sclerosis patients.Results: One-hundred and three relapsing-remitting multiple sclerosis patients – median age 41 years, median disease duration 6 years, median EDSS score 1 - and 80 healthy subjects were included. Alterations in autonomic function were reported in 97.1% of the cases, with statistical significance in orthostatic intolerance and gastrointestinal domain scores. Nevertheless, the difference between multiple sclerosis patients (41.7%) without confounding factors that could interfere with autonomic dysfunction (i.e. comorbidities or medications) and controls showed no statistical significance.Discussion: Our results may be related to the short disease duration, young age and lowdisability status of our patients unaffected by confounding factors. The questionnaire was not designed specifically for multiple sclerosis and it may not be as sensible to early autonomic symptoms as to more severe manifestations.Conclusions: Further studies are needed to achieve more robust results, validate this questionnaire and assess its application in multiple sclerosis patients in Portugal.Keywords: Autonomic Nervous System; Multiple Sclerosis; Portugal; Questionnaires.Introdução: A disfunção do sistema nervoso autónomo é comum na esclerose múltipla e deveria ser explorada na avaliação de rotina. O questionário Composite Autonomic Symptom Score foi validado como instrumento de auto-avaliação de sintomas autonómicos.Objetivos: Determinar a frequência de sintomas autonómicos em doentes com esclerose múltipla através de uma versão portuguesa do Composite Autonomic Symptom Score; comparar os resultados do questionário entre um grupo de doentes e um grupo controlo; avaliar a viabilidade da aplicação deste questionário em doentes portugueses.Material e Métodos: Neste estudo caso-controlo utilizou-se uma tradução portuguesa do questionário para determinar a frequência de sintomas autonómicos em doentes com esclerose múltipla.Resultados: Incluíram-se 103 doentes com esclerose múltipla surto-remissão – idade média 41 anos, mediana de duração da doença 6 anos, EDSS médio 1 - e 80 indivíduos saudáveis. Dos doentes, 97,1% tinham alterações da função autonómica, com significado estatístico nos domínios intolerância ortostática e gastrointestinal. Não encontramos diferenças estatísticas entre doentes (41,7%) sem fatores de confundimento que podiam interferir com a função autonómica (i.e. comorbilidades ou medicações) e o grupo controlo.Discussão: Os resultados obtidos podem estar relacionados com a curta duração de doença, idade jovem e baixo grau de incapacidade dos doentes sem fatores de confundimento. O questionário utilizado não foi desenhado especificamente para a esclerose múltipla e pode não ser tão sensível para sintomas autonómicos mais precoces como para manifestações mais graves da doença.Conclusões: Outros estudos serão necessários para obter resultados mais robustos, validar este questionário e avaliar a sua aplicação nos doentes portugueses.Palavras-chave: Esclerose Múltipla; Portugal; Questionários; Sistema Nervoso Autónomo.Ordem dos Médicos2015-02-27info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfimage/jpeghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562oai:ojs.www.actamedicaportuguesa.com:article/5562Acta Médica Portuguesa; Vol. 28 No. 1 (2015): January-February; 51-55Acta Médica Portuguesa; Vol. 28 N.º 1 (2015): Janeiro-Fevereiro; 51-551646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPengporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/4236https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/4213https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7286https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7287https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7574Vieira, BitiaCosta, AndreiaVideira, GonçaloSá, Maria JoséAbreu, Pedroinfo:eu-repo/semantics/openAccess2022-12-20T11:04:24Zoai:ojs.www.actamedicaportuguesa.com:article/5562Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:07.409488Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis
Prevalência da Disfunção Autonómica em Doentes com Esclerose Múltipla
title Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis
spellingShingle Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis
Vieira, Bitia
title_short Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis
title_full Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis
title_fullStr Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis
title_full_unstemmed Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis
title_sort Prevalence of Autonomic Dysfunction in Patients with Multiple Sclerosis
author Vieira, Bitia
author_facet Vieira, Bitia
Costa, Andreia
Videira, Gonçalo
Sá, Maria José
Abreu, Pedro
author_role author
author2 Costa, Andreia
Videira, Gonçalo
Sá, Maria José
Abreu, Pedro
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Vieira, Bitia
Costa, Andreia
Videira, Gonçalo
Sá, Maria José
Abreu, Pedro
description Background: Autonomic nervous system dysfunction is commonly seen in multiple sclerosis patients and should be explored in the routine evaluation. Composite Autonomic Symptom Score questionnaire was validated as a self-assessment instrument of autonomic symptoms.Objectives: Determine the frequency of autonomic symptoms in multiple sclerosis patients through a Portuguese version of Composite Autonomic Symptom Score; compare questionnaire results between patients and a control group; assess the feasibility of this questionnaire application in multiple sclerosis Portuguese patients.Material and Methods: This case-control study used a Portuguese translated version of Composite Autonomic Symptom Score to determine the frequency of autonomic symptoms in multiple sclerosis patients.Results: One-hundred and three relapsing-remitting multiple sclerosis patients – median age 41 years, median disease duration 6 years, median EDSS score 1 - and 80 healthy subjects were included. Alterations in autonomic function were reported in 97.1% of the cases, with statistical significance in orthostatic intolerance and gastrointestinal domain scores. Nevertheless, the difference between multiple sclerosis patients (41.7%) without confounding factors that could interfere with autonomic dysfunction (i.e. comorbidities or medications) and controls showed no statistical significance.Discussion: Our results may be related to the short disease duration, young age and lowdisability status of our patients unaffected by confounding factors. The questionnaire was not designed specifically for multiple sclerosis and it may not be as sensible to early autonomic symptoms as to more severe manifestations.Conclusions: Further studies are needed to achieve more robust results, validate this questionnaire and assess its application in multiple sclerosis patients in Portugal.Keywords: Autonomic Nervous System; Multiple Sclerosis; Portugal; Questionnaires.
publishDate 2015
dc.date.none.fl_str_mv 2015-02-27
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562
oai:ojs.www.actamedicaportuguesa.com:article/5562
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/5562
dc.language.iso.fl_str_mv eng
por
language eng
por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/4236
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/4213
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7286
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7287
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5562/7574
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
image/jpeg
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 28 No. 1 (2015): January-February; 51-55
Acta Médica Portuguesa; Vol. 28 N.º 1 (2015): Janeiro-Fevereiro; 51-55
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130642311544832